MAPK1 and neoplasm: The MAPK/ERK signaling pathway has been extensively studied in the context of tumor diseases (65, 66), and several lines of evidence indicate that overexpression and activation of ERK/MAPK plays an important role in the progression of allergic inflammation (67–70).